Mabthera-Reditux

MABTHERA:

It contains the Drug / Molecule  “Rituximab”.

RITUXIMAB has been innovated by ROCHE with the brand name  MABTHERA.

USAGE & DISCRIPTION :

MABTHERA has used  for certain types of cancer such as Lymphomas, Leukemia, Transplant Rejection and some autoimmune disorders. it may be used alone or in combination with other drugs for the treatment of Non-Hodgkin's Lymphoma and rheumatoid arthritis. 

.

CLINICAL APPLICATIONS :

it is produced through recombinant DNA technology. Reditux is a monoclonal antibody against the protein found on the surface of immune system B cells. It induces cell death through antibody dependent cellular toxicity, complement dependent cytotoxicity, or apoptosis pathway.

STORAGE:

Store under refrigeration between 2°C - 8°C and protect from direct sunlight.
Infusion solutions may be stored at 2°C − 8°C for 24 hours. 

Reditux is generic version of MABTHERA . Both contain same  Drug / Molecule “Rituximab”.

                                                   REDITUX

REDITUX:

It contains the Drug / Molecule  “Rituximab”.

REDITUX is generic version of MABTHERA.

USAGE & DISCRIPTION :

REDITUX has used  for certain types of cancer such as Lymphomas, Leukemia, Transplant Rejection and some autoimmune disorders. it may be used alone or in combination with other drugs for the treatment of Non-Hodgkin's Lymphoma and rheumatoid arthritis. 

.

CLINICAL APPLICATIONS :

it is produced through recombinant DNA technology. Reditux is a monoclonal antibody against the protein found on the surface of immune system B cells. It induces cell death through antibody dependent cellular toxicity, complement dependent cytotoxicity, or apoptosis pathway.

STORAGE:

Store under refrigeration between 2°C - 8°C and protect from direct sunlight.
Infusion solutions may be stored at 2°C − 8°C for 24 hours.